Item 1A. Risk Factors

There have been no material changes from the risk factors previously disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Set forth below is a summary of the shares repurchased by the Company during the three months ended March 31, 2025, and the number of shares remaining authorized for purchase by the Company:


	Total number of shares purchased	Average price paid per share		Total number of shares purchased as part of publicly announced plans or programs	Maximum number of shares that may yet be purchased under the plans or programs



January 2025	850,000	$	57.89	850,000	13,308,928
February 2025	—	$	—	—	13,308,928
March 2025	—	$	—	—	13,308,928

Previous: Item 4. Controls and Procedures · Next: Item 5. Other Information